Correlation between HDL function and coronary artery plaque
CSTR:
Author:
Affiliation:

1.School of Basic Medical Sciences, Wuhan University & Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, Hubei 430071, China;2.Yichang Hospital of Traditional Chinese Medicine, Yichang, Hubei 443100, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [18]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To explore the correlation between plasma HDL function and coronary artery stenosis and plaque property in coronary artery disease (CAD) patients with normal HDLC levels (≥1.03 mmol/L). Methods 129 cases suspected CAD with normal HDLC levels in Yichang Hospital of Traditional Chinese Medicine from October 2015 to December 2017 were enrolled, and grouped according to the severity of coronary artery stenosis and plaque property by 64-slice spiral CT coronary angiography (CTA). Paraoxonase 1 (PON1) activity and HDL oxidation/antioxidant index were detected. Results Compared with non-CAD group, plasma HDLC level and PON1 activity were significantly decreased, and HDL oxidation/antioxidant index was increased in the CAD group, showing an oxidized state, while ApoAI level had no difference. Although there were no difference in HDLC and ApoAI levels, PON1 activity was gradually decreased and HDL oxidation/antioxidant index was increased, accompanying with increased stenosis of coronary artery. The data also showed that PON1 activity of calcified plaque group was higher than that of soft plaque group and mixed plaque group. There is a correlation between PON1 activity and HDLC, HDL oxidation/antioxidant index. Conclusion PON1 activity as an index of HDL function may be a potential biomarker for assessment of the plaque property and severity of CAD.

    Reference
    [1] Cao YN, Xu L, Han YC, et al.Recombinant high-density lipoproteins and their use in cardiovascular diseases.Drug Discov Today, 7,2(1):180-185.
    [2] 张诗岚, 杜晓, 刘玲.高密度脂蛋白胆固醇水平与高密度脂蛋白功能:孰是孰非.中国动脉硬化杂志, 7,5(1):90-94.
    [3] 尔璐, 边云飞, 宋晓苏, 等.失功能高密度脂蛋白与心血管疾病研究进展.中国动脉硬化杂志, 7,5(3):309-313.
    [4] Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, et al.Dysfunctional HDL:a novel important diagnostic and therapeutic target in cardiovascular disease.Prog Lipid Res, 2,1(4):314-324.
    [5] Zhao Y, Ma Y, Fang Y, et al.Association between PON1 activity and coronary heart disease risk:a meta-analysis based on 43 studies.Mol Genet Metab, 2,5(1):141-148.
    [6] Zhou C, Cao J, Shang L, et al.Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.Dis Markers, 3,5(2):97-103.
    [7] Navab M, Hama SY, Hough GP, et al.A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.J Lipid Res, 1,2(8):1308-1317.
    [8] Cao J, Xu Y, Li F, et al.Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice.J Transl Med, 8,6(1):155.
    [9] Kontush A, Chapman MJ.Functionally defective high-density lipoprotein:a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.Pharmacol Rev, 6,8(3):342-374.
    [10] 肖冲冲, 黄贤胜, 丁振江, 等.64排螺旋CT冠状动脉成像对冠心病诊断准确性的影响因素分析.临床心血管病杂志, 6,2(3):245-250.
    [11] 诸骏仁, 高润霖, 赵水平, 等.中国成人血脂异常防治指南(2016年修订版).中国循环杂志, 6,1(10):937-953.
    [12] Perla-Kajan J, Jakubowski H.Paraoxonase 1 and homocysteine metabolism.Amino Acids, 2,3(4):1405-1417.
    [13] Ng DS, Chu T, Esposito B, et al.Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia.Cardiovasc Pathol, 8,7(4):226-232.
    [14] Getz GS, Reardon CA.Paraoxonase, a cardioprotective enzyme:continuing issues.Curr Opin Lipidol, 4,5(3):261-267.
    [15] Sun T, Hu J, Yin Z, et al.Low serum paraoxonase1 activity levels predict coronary artery disease severity.Oncotarget, 7,8(12):19443-19454.
    [16] Gupta N, Binu KB, Singh S, et al.Low serum PON1 activity:an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.Gene, 2,8(1):13-19.
    [17] Shunmoogam N, Naidoo P, Chilton R.Paraoxonase (PON)-1:a brief overview on genetics, structure, polymorphisms and clinical relevance.Vasc Health Risk Manag, 8,4:137-143.
    [18] Ansell BJ, Navab M, Hama S, et al.Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.Circulation, 3,8(22):2751-2756.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

CAO Jia, LIU Faquan, YU Hong. Correlation between HDL function and coronary artery plaque[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(10):1045-1051.

Copy
Share
Article Metrics
  • Abstract:928
  • PDF: 920
  • HTML: 0
  • Cited by: 0
History
  • Received:July 24,2018
  • Revised:September 18,2018
  • Online: November 09,2018
Article QR Code